Delivery Order SPE2DB20D2104-SPE2DB23FV49T
- Not listed
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract has a firm fixed price, a ceiling value of $2,415.07, and an ultimate completion date of April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Timolol 0.5% gel-solution, a medication used to treat glaucoma. The contract has a firm fixed price of $1,369.92 and a period of performance through May 14, 2025. The contract is not set-aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.25% Gel-Solution, a medication used to treat certain eye conditions. The contract has a ceiling value of $2,378.70 and a period of performance ending on June 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The total ceiling value of the contract is $6,034.95, and the ultimate completion date is June 16, 2025. This contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp is a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Timolol 0.5% Gel-Solution 5ML, a prescription eye medication, with a ceiling value of $1,659.44 and a period of performance through April 2025. The contract is not set aside and was awarded as a firm-fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,336.04, is for the supply of Timolol 0.25% Gel-Solution 5ML, a medication used to treat glaucoma. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.25% Gel-Solution, a medical eye drop product, with a ceiling value of $9,324.26 and an ultimate completion date of February 7, 2024. The contract is a firm fixed-price agreement, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $5,330.21, is for the delivery of Timolol 0.5% Gel-Solution 5ML, a medication used to treat certain types of glaucoma and high eye pressure. The contract has a period of performance through December 9, 2024 and is a firm fixed-price contract....
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Timolol 0.5% Gel-Solution, a prescription eye medication, with a ceiling value of $6,308.29 and an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
- This federal contract award is a delivery order (SPE2DB23FU60L) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,525.25 firm fixed-price contract is for the delivery of 4,561,625,810 units of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract has a completion date of July 28, 2023 and was awarded on July 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV49TDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.25% gel-solution, a medication used to treat glaucoma. The contract has a ceiling value of $8,363.49 and runs through September 25, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 9/22/23 |